Unknown

Dataset Information

0

The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded A? and prion proteins.


ABSTRACT: Current evidence indicating a role of the human prion protein (PrP) in amyloid-beta (A?) formation or a synergistic effect between A? and prion pathology remains controversial. Conflicting results also concern the frequency of the association between the two protein misfolding disorders and the issue of whether the apolipoprotein E gene (APOE) and the prion protein gene (PRNP), the major modifiers of A?- and PrP-related pathologies, also have a pathogenic role in other proteinopathies, including tau neurofibrillary degeneration. Here, we thoroughly characterized the Alzheimer's disease/primary age-related tauopathy (AD/PART) spectrum in a series of 450 cases with definite sporadic or genetic Creutzfeldt-Jakob disease (CJD). Moreover, we analyzed: (i) the effect of variables known to affect CJD pathogenesis and the co-occurring A?- and tau-related pathologies; (II) the influence of APOE genotype on CJD pathology, and (III) the effect of AD/PART co-pathology on the clinical CJD phenotype. AD/PART characterized 74% of CJD brains, with 53.3% and 8.2% showing low or intermediate-high levels of AD pathology, and 12.4 and 11.8% definite or possible PART. There was no significant correlation between variables affecting CJD (i.e., disease subtype, prion strain, PRNP genotype) and those defining the AD/PART spectrum (i.e., ABC score, Thal phase, prevalence of CAA and Braak stage), and no difference in the distribution of APOE ?4 and ?2 genotypes among CJD subtypes. Moreover, AD/PART co-pathology did not significantly affect the clinical presentation of typical CJD, except for a tendency to increase the frequency of cognitive symptoms. Altogether, the present results seem to exclude an increased prevalence AD/PART co-pathology in sporadic and genetic CJD, and indicate that largely independent pathogenic mechanisms drive AD/PART and CJD pathology even when they coexist in the same brain.

SUBMITTER: Rossi M 

PROVIDER: S-EPMC6454607 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins.

Rossi Marcello M   Kai Hideaki H   Baiardi Simone S   Bartoletti-Stella Anna A   Carlà Benedetta B   Zenesini Corrado C   Capellari Sabina S   Kitamoto Tetsuyuki T   Parchi Piero P  

Acta neuropathologica communications 20190408 1


Current evidence indicating a role of the human prion protein (PrP) in amyloid-beta (Aβ) formation or a synergistic effect between Aβ and prion pathology remains controversial. Conflicting results also concern the frequency of the association between the two protein misfolding disorders and the issue of whether the apolipoprotein E gene (APOE) and the prion protein gene (PRNP), the major modifiers of Aβ- and PrP-related pathologies, also have a pathogenic role in other proteinopathies, including  ...[more]

Similar Datasets

| S-EPMC5120774 | biostudies-literature
| S-EPMC8595465 | biostudies-literature
| S-EPMC7663943 | biostudies-literature
| S-EPMC6916291 | biostudies-literature
| S-EPMC5884914 | biostudies-literature
| S-EPMC4641021 | biostudies-literature
| S-EPMC9313290 | biostudies-literature
| S-EPMC8471964 | biostudies-literature
| S-EPMC6981053 | biostudies-literature
| S-EPMC4789256 | biostudies-literature